Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
71 1.4% |
 |
Gilead SciencesGILD |
53 0% |
 |
Catalyst PharmaceuticalsCPRX |
100 0% |
 |
Inovio PharmaceuticalsINO |
23 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
Month over Month
Employee view on business outlook (0 - 100)
| Aug 2025 | 38 | |
| Jul 2025 | 35 | |
| Jun 2025 | 39 | |
| May 2025 | 44 |
How do employees feel about the future at 10X Genomics?
The Business Outlook at 10X Genomics is negative, according to employees. The rating, which is an average compiled from the top review sites in the US, is below average at 40 out of 100. Additionally, this rating has been trending downward in comparison to the previous month. But the rating is up, compared to previous month.
Analyzing Business Outlook, how is 10X Genomics performing compared to its industry peers?
Compared to its peers, 10X Genomics ranks in the 40th percentile when it comes to Business Outlook.
How has the business outlook at 10X Genomics changed over the last couple of months
There has been no meaningful change in the business outlook amongst employees at 10X Genomics.
Why is it important to track the business outlook at 10X Genomics?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at 10X Genomics.
